These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 929148)

  • 41. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.
    Terzolo M; Boccuzzi A; Ali A; Bollito E; De Risi C; Paccotti P; Angeli A
    J Endocrinol Invest; 1997 May; 20(5):270-5. PubMed ID: 9258806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    JAMA; 1979 Oct; 242(15):1640-3. PubMed ID: 39183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
    N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Domínguez Ortega L
    Rev Clin Esp; 1992 Jul; 191(3):169. PubMed ID: 1502409
    [No Abstract]   [Full Text] [Related]  

  • 48. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE; Rosenfeld PS; Bokat MA
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of cortisol secretion by low-dose dexamethasone testing in Cushing's disease. Case report.
    King LW; Post KD; Yust I; Reichlin S
    J Neurosurg; 1983 Jan; 58(1):129-32. PubMed ID: 6847900
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Estruch R; Tassies D; Beltrán J; Halperin EI
    Rev Clin Esp; 1991 Nov; 189(7):344-5. PubMed ID: 1767094
    [No Abstract]   [Full Text] [Related]  

  • 53. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cushing's syndrome secondary to ectopic cortisol production by an ovarian carcinoma.
    Marieb NJ; Spangler S; Kashgarian M; Heimann A; Schwartz ML; Schwartz PE
    J Clin Endocrinol Metab; 1983 Oct; 57(4):737-40. PubMed ID: 6309883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iatrogenic Cushing syndrome due to nasal steroid drops.
    Baş VN; Cetinkaya S; Aycan Z
    Eur J Pediatr; 2012 Apr; 171(4):735-6. PubMed ID: 22203429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cushing's syndrome due to abuse of dexamethasone nasal spray.
    Ortega LD; Grande RG
    Lancet; 1979 Jul; 2(8133):96. PubMed ID: 87988
    [No Abstract]   [Full Text] [Related]  

  • 58. Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops.
    Daman Willems CE; Dinwiddie R; Grant DB; Rivers RP; Zahir M
    Eur J Pediatr; 1994 Sep; 153(9):632-4. PubMed ID: 7957419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cushing syndrome due to surreptitious glucocorticoid administration.
    Quddusi S; Browne P; Toivola B; Hirsch IB
    Arch Intern Med; 1998 Feb; 158(3):294-6. PubMed ID: 9472211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cushing syndrome related to gingival application of a dexamethasone-containing preparation.
    Pichardo-Lowden A; Manni A
    Endocr Pract; 2010; 16(2):336. PubMed ID: 20361416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.